Wikidata

(Q64121118)

English

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

clinical trial

In more languages

Statements

title
Ibritumomab Tiuxetan and High-Dose Melphalan as Conditioning Regimen Before Autologous Stem Cell Transplantation for Elderly Patients With Lymphoma in Relapse or Resistant to Chemotherapy. A Multicenter Phase I Trial (English)
0 references
country
Switzerland
0 references
start time
October 2006
0 references
end time
December 2012
0 references
number of participants
20
0 references
research intervention
rituximab
0 references
melphalan
0 references
minimum age
65 year
0 references
maximum age
120 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64121118&oldid=1857548023"